In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters-Reference-Cited by-同舟云学术

In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters

Published:2006-06 Issue:4 Volume:79 Page:317-323
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Tóth Orsolya,Szabó Csaba,Kecskés Marianna,Pótó László,Nagy Ágnes,Losonczy Hajna

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference30 articles.

1. Inhibition of ADP-evoked platelet aggregation by selected poly(ADP-ribose) polymerase inhibitors;Alexy;Journal of Cardiovascular Pharmacology,2004

2. Effect of adenosine diphosphate on the concentration of platelets in circulating blood;Born;Nature,1963

3. A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time;Boudjeltia;BioMed Central Biotechnology,2002

4. Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress;Chatterjee;Kidney International,1999

5. Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications — a review;Fabris;Archives of Pathology and Laboratory Medicine,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Early Intravenous Haemostatic Drugs on Brain Haemorrhage Patients and Their Image Segmentation Based on RGB-D Images;Journal of Healthcare Engineering;2022-01-07

2. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice;Molecular Neurobiology;2018-04-12

3. A comprehensive look of poly(ADP-ribose) polymerase inhibition strategies and future directions for cancer therapy;Future Medicinal Chemistry;2017-01

4. Another “String to the Bow” of PJ34, a Potent Poly(ADP-Ribose)Polymerase Inhibitor: An Antiplatelet Effect through P2Y12 Antagonism?;PLoS ONE;2014-10-20

5. New Poly(ADP-ribose) Polymerase-1 Inhibitors with Antioxidant Activity Based on 4-Carboxamidobenzimidazole-2-ylpyrroline and -tetrahydropyridine Nitroxides and Their Precursors;Journal of Medicinal Chemistry;2009-02-26